SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report

BACKGROUND: Immunocompromised patients are at increased risk of SARS-CoV-2 infections. Patients undergoing chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory B-cell malignancies are uniquely immunosuppressed due to CAR T-mediated B-cell aplasia (BCA). While SARS-CoV-2 mortality r...

Descripción completa

Detalles Bibliográficos
Autores principales: McNerney, Kevin Owen, Richards, Rebecca M, Aguayo-Hiraldo, Paibel, Calkoen, Friso G, Talano, Julie-An, Moskop, Amy, Balduzzi, Adriana, Krajewski, Jennifer, Dave, Hema, Vatsayan, Anant, Callahan, Colleen, Liu, Hongyan, Li, Yimei, Davis, Kara Lynn, Maude, Shannon L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884906/
https://www.ncbi.nlm.nih.gov/pubmed/36707090
http://dx.doi.org/10.1136/jitc-2022-005957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884906/
https://www.ncbi.nlm.nih.gov/pubmed/36707090
http://dx.doi.org/10.1136/jitc-2022-005957

Ejemplares similares